Location · Arizona
Clinical trials recruiting in Arizona
621 recruiting studies have at least one site in Arizona; 136 accept healthy volunteers. Studies that need a specific condition are included too, so check each listing.
Want the research companies that run paid Phase 1 studies for healthy volunteers? Paid clinical trial companies in Arizona.
621 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
More recruiting studies (pay not posted)
- Recruiting
Miro3D Wound Matrix for Treatment of Diabetic Foot Ulcers
Reprise Biomedical, Inc.
- Location
- Phoenix, AZ + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
GlaxoSmithKline
- Location
- Phoenix, AZ + 29 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 2/Phase 3
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
Chiesi Farmaceutici S.p.A.
- Location
- Phoenix, AZ + 5 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Eli Lilly and Company
- Location
- Tucson, AZ + 39 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 3
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
X4 Pharmaceuticals
- Location
- Phoenix, AZ + 20 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 2/Phase 3
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
EyeBiotech Ltd.
- Location
- Gilbert, AZ + 51 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 2
Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
Adverum Biotechnologies, Inc.
- Location
- Phoenix, AZ + 11 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
BlueRock Therapeutics
- Location
- Scottsdale, AZ + 33 other US sites
- Eligibility basics
- Ages 45–75
- Recruiting
Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus
Well Cell Global
- Location
- Phoenix, AZ + 1 other US site
- Eligibility basics
- Ages 18+
- Recruiting
ATLAS (AltaValve) Pivotal Trial
4C Medical Technologies, Inc.
- Location
- Phoenix, AZ + 35 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
GlaxoSmithKline
- Location
- Chandler, AZ + 28 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 2/Phase 3
A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
Janssen Research & Development, LLC
- Location
- Phoenix, AZ + 7 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 2
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Artiva Biotherapeutics, Inc.
- Location
- Phoenix, AZ + 29 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease
Sanmai Technologies PBC dba Sanmai
- Location
- Tucson, AZ + 3 other US sites
- Eligibility basics
- Ages 22–80
- RecruitingPhase 1
Semaglutide Delivered Epi-Intradermally by Microarray Patch (VX-201) Versus Subcutaneous Administration in Healthy Overweight and Obese Participants
Terrestrial Bio, Inc.
- Location
- Tempe, AZ
- Eligibility basics
- Ages 18–60
- RecruitingPhase 3
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Immunovant Sciences GmbH
- Location
- Phoenix, AZ + 47 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
RAPT Therapeutics, Inc., a member of the GSK plc group of companies
- Location
- Phoenix, AZ + 21 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingPhase 2
Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis
Novaliq GmbH
- Location
- Phoenix, AZ + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Janssen Research & Development, LLC
- Location
- Paradise Valley, AZ + 10 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Syndeio Biosciences, Inc
- Location
- Phoenix, AZ + 22 other US sites
- Eligibility basics
- Ages 18–64
- RecruitingPhase 3
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
GlaxoSmithKline
- Location
- Chandler, AZ + 62 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
Axsome Therapeutics, Inc.
- Location
- Chandler, AZ + 37 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS
PhenoNet, Inc.
- Location
- Scottsdale, AZ + 4 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
Navigator Medicines, Inc.
- Location
- Phoenix, AZ + 13 other US sites
- Eligibility basics
- Ages 18–70